Clinical Trials Browser

Recruiting × INDUSTRY × Hodgkin Disease × Clear all

NCT07623850 2026-06-03

JLM019

Phase 1 Recruiting

Hodgkin Disease, Lymphoma, Non-Hodgkin

NCT05100056 2026-05-27

BV-MAZOVIA

Hodgkin Disease

NCT06137144 2026-05-19

PRIMAVERA

Phase 1/2 Recruiting

Hodgkin Disease, Lymphoma, Lymphoma, Non-Hodgkin, Lymphoma, T-Cell, Peripheral

NCT06150664 2026-04-20

A Phase 1 of CTX-8371 in Patients With Advanced Malignancies

Phase 1 Recruiting

BreastDermatologicHead & NeckLymphoidThoracic

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung, Hodgkin Disease, Melanoma, Triple Negative Breast Neoplasms

NCT05481437 2026-04-13

A Survey of Brentuximab Vedotin in Pediatric Participants With Hodgkin Lymphoma

Hodgkin Disease

NCT06487624 2026-04-13

An Engineered Sirpα Fused to Anti-Pd-L1 And Tgf-β Fusion Protein (HCB301) in Subjects With Selected Advanced Tumors

Phase 1 Recruiting

Camurati-Engelmann Syndrome, Hodgkin Disease, Neoplasms

NCT06915246 2026-03-27

A Study of Carmustine With and Without Ethanol in Subjects With Lymphoma

Phase 2 Recruiting

Hodgkin Disease, Lymphoma, Lymphoma, Non-Hodgkin

NCT05589896 2026-02-24

A First-in-Human Study of HLA-Partially to Fully Matched Allogenic Cryopreserved Deceased Donor Bone Marrow Transplantation for Patients With Hematologic Malignancies

Phase 1/2 Recruiting

Classical hematologyDermatologicLymphoidMyeloidOther hematologic neoplasm

Anemia, Refractory, with Excess of Blasts, Hematologic Diseases, Hodgkin Disease, Leukemia, Lymphoma, Leukemia, B-Cell, Leukemia, Biphenotypic, Acute, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Lymphoma, T-Cell, Cutaneous, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT06831370 2026-02-23

A Study of Brentuximab Vedotin With Doxorubicin, Vinblastine and Dacarbazine in Adults With Hodgkin Lymphoma in India

Phase 4 Recruiting

Hodgkin Disease, Lymphoma

NCT06755450 2026-01-13

ADITI-1

Phase 1 Recruiting

Hodgkin Disease, Lymphoma, Non-Hodgkin

NCT05798897 2025-08-20

APOLLO

Phase 1 Recruiting

Hodgkin Disease, Lymphoma, Lymphoma, Non-Hodgkin, Recurrence